滚动资讯
CellA skin-hypothalamus axis couples heat stress and metabolic dysfunctionCellThe evolution of high-order genome architecture revealed from 1,000 speciesCellSomatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative statesCellPyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylationCellMechanism-guided identification of antidepressant G protein-coupled receptor drug targetsBDArea Softball: PRB gets 2 wins - Brainerd DispatchFierceBiotechWCG收购The Contract Network，旨在简化临床试验执行流程RecursionRecursion Pharmaceuticals director Gibson sells $144,400 in stock By Investing.com - Investing.com CanadaRecursionRecursion Pharmaceuticals (NASDAQ: RXRX) director sells 40K shares under plan - Stock TitanRecursion[SCHEDULE 13G/A] RECURSION PHARMACEUTICALS, INC. Amended Passive Investment Disclosure - Stock Titan
BioWorld 2025年12月5日

Onco3r Therapeutics专利披露新型FGFR3抑制剂

Onco3r Therapeutics专利披露新型FGFR3抑制剂

原文
暂时没有全文，请查看原始来源。